{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:35:31Z","timestamp":1772746531304,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf00428187","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T23:44:56Z","timestamp":1100130296000},"page":"277-283","source":"Crossref","is-referenced-by-count":40,"title":["Amphetamine response and relapse risk after depot neuroleptic discontinuation"],"prefix":"10.1007","volume":"85","author":[{"given":"B.","family":"Angrist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Peselov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wolkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rotrosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00433802","volume":"72","author":"B Angrist","year":"1980","unstructured":"Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia. Psychopharmacology 72:17?19","journal-title":"Psychopharmacology"},{"key":"CR2","series-title":"Advances in the biosciences","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-08-026382-3.50010-4","volume-title":"Recent advances in neuropsychopharmacology","author":"B Angrist","year":"1981","unstructured":"Angrist B, Peselow E, Rotrosen J, Gershon S (1981) Relationships between responses to dopamine agonists, psychopathology, neuroleptic treatment response, and need for neuroleptic maintenance in schizophrenic subjects. In: Angrist B et al. (eds) Recent advances in neuropsychopharmacology. Pergamon, Oxford New York (Advances in the biosciences, vol 31, pp 49?54)"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00432248","volume":"78","author":"B Angrist","year":"1982","unstructured":"Angrist B, Peselow E, Robenstein M, Corwin J, Rotrosen J (1982) Partial improvement in negative schizophrenic symptoms after amphetamine. Psychoparmacology 78:128?130","journal-title":"Psychoparmacology"},{"key":"CR4","first-page":"993","volume-title":"Psychopharmacology: A generation of progress","author":"RJ Baldessarini","year":"1978","unstructured":"Baldessarini RJ, Tarsy D (1978) Tardive dyskinesia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress, Raven, New York, pp 993?1004"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/ajp.138.4.570","volume":"138","author":"WA Brown","year":"1981","unstructured":"Brown WA, Laughren T (1981) Low serum prolactin and early relapse following neuroleptic withdrawal. Am J Psychiatry 138:237?239","journal-title":"Am J Psychiatry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","volume":"280","author":"TJ Crow","year":"1980","unstructured":"Crow TJ (1980) Molecular pathology in schizophrenia: More than one disease process? Br Med J 280:66?68","journal-title":"Br Med J"},{"key":"CR7","first-page":"491","volume":"42","author":"J Delay","year":"1947","unstructured":"Delay J (1947) Pharmacological exploration of the personality: Narcoanalysis and methadrine shock. Proc R Soc Med 42:491?496","journal-title":"Proc R Soc Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/bmj.1.3984.1013","volume":"1","author":"E Guttman","year":"1937","unstructured":"Guttman E, Sargant W (1937) Observations on benzedrine. Br Med J 1:1013?1015","journal-title":"Br Med J"},{"key":"CR9","volume-title":"ECDEU Assessment manual for psychopathology","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU Assessment manual for psychopathology. US Department of Health, Education and Welfare, Washington, DC"},{"key":"CR10","first-page":"67","volume":"12","author":"JM Hope","year":"1951","unstructured":"Hope JM, Callaway E, Sands L (1951) Intravenous pervitan and the psychopathology of schizophrenia. Dis Nerv Syst 12:67?72","journal-title":"Dis Nerv Syst"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1973.01750320023004","volume":"28","author":"DS Janowsky","year":"1973","unstructured":"Janowsky DS, El-Yousef K, Davis JM, Sekerke J (1973) Provocation of schizophrenic symptoms by intravenous methylphenidate. Arch Gen Psychiatry 28:185?191","journal-title":"Arch Gen Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/jcem-45-5-996","volume":"45","author":"G Langer","year":"1977","unstructured":"Langer G, Sachar ES, Halper FS, Gruen PH, Solomen M (1977) The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: Neuroendocrine studies in normal men. J Clin Endocrinol Metab 45:996?1002","journal-title":"J Clin Endocrinol Metab"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1176\/ajp.141.12.1633","volume":"141","author":"J Lieberman","year":"1984","unstructured":"Lieberman J, Kane J, Gadaletta D, Brenner R, Lesser M, Kinon B (1984) Methylphenidate challenge as a predictor of relapse in schizophrenia. Am J Psychiatry 141:633?638","journal-title":"Am J Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jama.1968.03140180050018","volume":"204","author":"RH Mattson","year":"1968","unstructured":"Mattson RH, Calverly JR (1968) Dextroamphetamine sulfate-induced dyskinesias. JAMA 204:400?402","journal-title":"JAMA"},{"key":"CR15","first-page":"603","volume-title":"Prog neuropsychopharmacol vol 5","author":"Z Merali","year":"1981","unstructured":"Merali Z (1981) Prolactin levels and amphetamine-induced behavioral changes following fluphenazine decanoate administration. In: Radouco-Thomas C, Garcin F (eds) Prog neuropsychopharmacol vol 5. Pergamon, Oxford New York, pp 603?607"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archneurpsyc.1936.02260100143005","volume":"36","author":"A Meyerson","year":"1936","unstructured":"Meyerson A (1936) Effect of benzedrine sulfate on mood and fatigue in normal and neurotic persons. Arch Neurol Psychiatry 36:816?822","journal-title":"Arch Neurol Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1001\/jama.1935.02760510023006","volume":"105","author":"M Prinzmetal","year":"1935","unstructured":"Prinzmetal M, Bloomberg W (1935) The use of benzedrine for the treatment of narcolepsy. JAMA 105:2051?2054","journal-title":"JAMA"},{"key":"CR18","first-page":"169","volume-title":"An introduction to physical methods of treatment in psychiatry","author":"W Sargant","year":"1954","unstructured":"Sargant W, Slater E (1954) An introduction to physical methods of treatment in psychiatry. Williams and Wilkins, Baltimore p 169"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/ajp.94.1.27","volume":"94","author":"PG Schube","year":"1937","unstructured":"Schube PG, McManamy MC, Trapp CE, Meyerson A (1937) The effect of benzedrine sulfate on certain abnormal mental states. Am J Psychiatry 94:27?32","journal-title":"Am J Psychiatry"},{"key":"CR20","first-page":"233","volume":"17","author":"DP Kammen Van","year":"1982","unstructured":"Van Kammen DP, Docherty JP, Bunney WE Jr (1982a) Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment. Biol Psychiatry 17:233?242","journal-title":"Biol Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1176\/ajp.139.8.991","volume":"139","author":"DP Kammen Van","year":"1982","unstructured":"Van Kammen DP, Bunney WE, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982b) d-Amphetamine-induced heterogenous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991?997","journal-title":"Am J Psychiatry"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(81)92334-5","volume":"1","author":"B Wistedt","year":"1981","unstructured":"Wistedt B, Wiles D, Kolakowska T (1981) Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics. Lancet 1:1163","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01563130","volume":"12","author":"LF Wooley","year":"1938","unstructured":"Wooley LF (1938) The clinical effect of benzedrine sulfate in mental patients with retarded activity. Psychiatr Q 12:66?83","journal-title":"Psychiatr Q"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00428187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00428187\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00428187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:38:04Z","timestamp":1554835084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00428187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF00428187"],"URL":"https:\/\/doi.org\/10.1007\/bf00428187","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}